Global Recombinant Collagen Medical Aesthetic Injection Supply, Demand and Key Producers, 2023-2029

Page: 108

Published Date: 10 Sep 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Recombinant Collagen Medical Aesthetic Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Recombinant Collagen Medical Aesthetic Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Collagen Medical Aesthetic Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Collagen Medical Aesthetic Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Collagen Medical Aesthetic Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Collagen Medical Aesthetic Injection total production value, 2018-2029, (USD Million)
Global Recombinant Collagen Medical Aesthetic Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Collagen Medical Aesthetic Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Collagen Medical Aesthetic Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Collagen Medical Aesthetic Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Collagen Medical Aesthetic Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Collagen Medical Aesthetic Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Recombinant Collagen Medical Aesthetic Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nasvita Medical, Mei Medica, Hyamax, Allergan Aesthetics, CollPlant, Giant Biogene Holding Co., Ltd, Jinbo Bio, Shuangmei Biotechnology Co., Ltd and Bloomage Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Collagen Medical Aesthetic Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Collagen Medical Aesthetic Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Collagen Medical Aesthetic Injection Market, Segmentation by Type
    Plant-derived Collagen
    Animal-derived Collagen

Global Recombinant Collagen Medical Aesthetic Injection Market, Segmentation by Application
    Hospital
    Beauty Agency

Companies Profiled:
    Nasvita Medical
    Mei Medica
    Hyamax
    Allergan Aesthetics
    CollPlant
    Giant Biogene Holding Co., Ltd
    Jinbo Bio
    Shuangmei Biotechnology Co., Ltd
    Bloomage Bio
    Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

Key Questions Answered
1. How big is the global Recombinant Collagen Medical Aesthetic Injection market?
2. What is the demand of the global Recombinant Collagen Medical Aesthetic Injection market?
3. What is the year over year growth of the global Recombinant Collagen Medical Aesthetic Injection market?
4. What is the production and production value of the global Recombinant Collagen Medical Aesthetic Injection market?
5. Who are the key producers in the global Recombinant Collagen Medical Aesthetic Injection market?

Table of Contents

1 Supply Summary
    1.1 Recombinant Collagen Medical Aesthetic Injection Introduction
    1.2 World Recombinant Collagen Medical Aesthetic Injection Supply & Forecast
        1.2.1 World Recombinant Collagen Medical Aesthetic Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Collagen Medical Aesthetic Injection Production (2018-2029)
        1.2.3 World Recombinant Collagen Medical Aesthetic Injection Pricing Trends (2018-2029)
    1.3 World Recombinant Collagen Medical Aesthetic Injection Production by Region (Based on Production Site)
        1.3.1 World Recombinant Collagen Medical Aesthetic Injection Production Value by Region (2018-2029)
        1.3.2 World Recombinant Collagen Medical Aesthetic Injection Production by Region (2018-2029)
        1.3.3 World Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Collagen Medical Aesthetic Injection Production (2018-2029)
        1.3.5 Europe Recombinant Collagen Medical Aesthetic Injection Production (2018-2029)
        1.3.6 China Recombinant Collagen Medical Aesthetic Injection Production (2018-2029)
        1.3.7 Japan Recombinant Collagen Medical Aesthetic Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Collagen Medical Aesthetic Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Collagen Medical Aesthetic Injection Major Market Trends

2 Demand Summary
    2.1 World Recombinant Collagen Medical Aesthetic Injection Demand (2018-2029)
    2.2 World Recombinant Collagen Medical Aesthetic Injection Consumption by Region
        2.2.1 World Recombinant Collagen Medical Aesthetic Injection Consumption by Region (2018-2023)
        2.2.2 World Recombinant Collagen Medical Aesthetic Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.4 China Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.5 Europe Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.6 Japan Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.7 South Korea Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.8 ASEAN Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)
    2.9 India Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029)

3 World Recombinant Collagen Medical Aesthetic Injection Manufacturers Competitive Analysis
    3.1 World Recombinant Collagen Medical Aesthetic Injection Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Collagen Medical Aesthetic Injection Production by Manufacturer (2018-2023)
    3.3 World Recombinant Collagen Medical Aesthetic Injection Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Collagen Medical Aesthetic Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Collagen Medical Aesthetic Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Collagen Medical Aesthetic Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Collagen Medical Aesthetic Injection in 2022
    3.6 Recombinant Collagen Medical Aesthetic Injection Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Collagen Medical Aesthetic Injection Market: Region Footprint
        3.6.2 Recombinant Collagen Medical Aesthetic Injection Market: Company Product Type Footprint
        3.6.3 Recombinant Collagen Medical Aesthetic Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Value Comparison
        4.1.1 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Comparison
        4.2.1 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Collagen Medical Aesthetic Injection Consumption Comparison
        4.3.1 United States VS China: Recombinant Collagen Medical Aesthetic Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Collagen Medical Aesthetic Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Collagen Medical Aesthetic Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023)
    4.5 China Based Recombinant Collagen Medical Aesthetic Injection Manufacturers and Market Share
        4.5.1 China Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023)
    4.6 Rest of World Based Recombinant Collagen Medical Aesthetic Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Collagen Medical Aesthetic Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Plant-derived Collagen
        5.2.2 Animal-derived Collagen
    5.3 Market Segment by Type
        5.3.1 World Recombinant Collagen Medical Aesthetic Injection Production by Type (2018-2029)
        5.3.2 World Recombinant Collagen Medical Aesthetic Injection Production Value by Type (2018-2029)
        5.3.3 World Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Collagen Medical Aesthetic Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Beauty Agency
    6.3 Market Segment by Application
        6.3.1 World Recombinant Collagen Medical Aesthetic Injection Production by Application (2018-2029)
        6.3.2 World Recombinant Collagen Medical Aesthetic Injection Production Value by Application (2018-2029)
        6.3.3 World Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Nasvita Medical
        7.1.1 Nasvita Medical Details
        7.1.2 Nasvita Medical Major Business
        7.1.3 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.1.4 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Nasvita Medical Recent Developments/Updates
        7.1.6 Nasvita Medical Competitive Strengths & Weaknesses
    7.2 Mei Medica
        7.2.1 Mei Medica Details
        7.2.2 Mei Medica Major Business
        7.2.3 Mei Medica Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.2.4 Mei Medica Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Mei Medica Recent Developments/Updates
        7.2.6 Mei Medica Competitive Strengths & Weaknesses
    7.3 Hyamax
        7.3.1 Hyamax Details
        7.3.2 Hyamax Major Business
        7.3.3 Hyamax Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.3.4 Hyamax Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Hyamax Recent Developments/Updates
        7.3.6 Hyamax Competitive Strengths & Weaknesses
    7.4 Allergan Aesthetics
        7.4.1 Allergan Aesthetics Details
        7.4.2 Allergan Aesthetics Major Business
        7.4.3 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.4.4 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Allergan Aesthetics Recent Developments/Updates
        7.4.6 Allergan Aesthetics Competitive Strengths & Weaknesses
    7.5 CollPlant
        7.5.1 CollPlant Details
        7.5.2 CollPlant Major Business
        7.5.3 CollPlant Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.5.4 CollPlant Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 CollPlant Recent Developments/Updates
        7.5.6 CollPlant Competitive Strengths & Weaknesses
    7.6 Giant Biogene Holding Co., Ltd
        7.6.1 Giant Biogene Holding Co., Ltd Details
        7.6.2 Giant Biogene Holding Co., Ltd Major Business
        7.6.3 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.6.4 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Giant Biogene Holding Co., Ltd Recent Developments/Updates
        7.6.6 Giant Biogene Holding Co., Ltd Competitive Strengths & Weaknesses
    7.7 Jinbo Bio
        7.7.1 Jinbo Bio Details
        7.7.2 Jinbo Bio Major Business
        7.7.3 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.7.4 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Jinbo Bio Recent Developments/Updates
        7.7.6 Jinbo Bio Competitive Strengths & Weaknesses
    7.8 Shuangmei Biotechnology Co., Ltd
        7.8.1 Shuangmei Biotechnology Co., Ltd Details
        7.8.2 Shuangmei Biotechnology Co., Ltd Major Business
        7.8.3 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.8.4 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
        7.8.6 Shuangmei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
    7.9 Bloomage Bio
        7.9.1 Bloomage Bio Details
        7.9.2 Bloomage Bio Major Business
        7.9.3 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.9.4 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Bloomage Bio Recent Developments/Updates
        7.9.6 Bloomage Bio Competitive Strengths & Weaknesses
    7.10 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
        7.10.1 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Details
        7.10.2 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Major Business
        7.10.3 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product and Services
        7.10.4 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recent Developments/Updates
        7.10.6 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Collagen Medical Aesthetic Injection Industry Chain
    8.2 Recombinant Collagen Medical Aesthetic Injection Upstream Analysis
        8.2.1 Recombinant Collagen Medical Aesthetic Injection Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Collagen Medical Aesthetic Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Collagen Medical Aesthetic Injection Production Mode
    8.6 Recombinant Collagen Medical Aesthetic Injection Procurement Model
    8.7 Recombinant Collagen Medical Aesthetic Injection Industry Sales Model and Sales Channels
        8.7.1 Recombinant Collagen Medical Aesthetic Injection Sales Model
        8.7.2 Recombinant Collagen Medical Aesthetic Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Collagen Medical Aesthetic Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Collagen Medical Aesthetic Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Collagen Medical Aesthetic Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Collagen Medical Aesthetic Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Recombinant Collagen Medical Aesthetic Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Recombinant Collagen Medical Aesthetic Injection Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Collagen Medical Aesthetic Injection Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Recombinant Collagen Medical Aesthetic Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Recombinant Collagen Medical Aesthetic Injection Major Market Trends
    Table 13. World Recombinant Collagen Medical Aesthetic Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Recombinant Collagen Medical Aesthetic Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Recombinant Collagen Medical Aesthetic Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Recombinant Collagen Medical Aesthetic Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Collagen Medical Aesthetic Injection Producers in 2022
    Table 18. World Recombinant Collagen Medical Aesthetic Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Recombinant Collagen Medical Aesthetic Injection Producers in 2022
    Table 20. World Recombinant Collagen Medical Aesthetic Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Recombinant Collagen Medical Aesthetic Injection Company Evaluation Quadrant
    Table 22. World Recombinant Collagen Medical Aesthetic Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Collagen Medical Aesthetic Injection Production Site of Key Manufacturer
    Table 24. Recombinant Collagen Medical Aesthetic Injection Market: Company Product Type Footprint
    Table 25. Recombinant Collagen Medical Aesthetic Injection Market: Company Product Application Footprint
    Table 26. Recombinant Collagen Medical Aesthetic Injection Competitive Factors
    Table 27. Recombinant Collagen Medical Aesthetic Injection New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Collagen Medical Aesthetic Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Collagen Medical Aesthetic Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Collagen Medical Aesthetic Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Recombinant Collagen Medical Aesthetic Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share (2018-2023)
    Table 37. China Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Collagen Medical Aesthetic Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share (2018-2023)
    Table 47. World Recombinant Collagen Medical Aesthetic Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Collagen Medical Aesthetic Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Recombinant Collagen Medical Aesthetic Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Recombinant Collagen Medical Aesthetic Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Collagen Medical Aesthetic Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Recombinant Collagen Medical Aesthetic Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Collagen Medical Aesthetic Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Recombinant Collagen Medical Aesthetic Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Recombinant Collagen Medical Aesthetic Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Collagen Medical Aesthetic Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Nasvita Medical Basic Information, Manufacturing Base and Competitors
    Table 62. Nasvita Medical Major Business
    Table 63. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 64. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Nasvita Medical Recent Developments/Updates
    Table 66. Nasvita Medical Competitive Strengths & Weaknesses
    Table 67. Mei Medica Basic Information, Manufacturing Base and Competitors
    Table 68. Mei Medica Major Business
    Table 69. Mei Medica Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 70. Mei Medica Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Mei Medica Recent Developments/Updates
    Table 72. Mei Medica Competitive Strengths & Weaknesses
    Table 73. Hyamax Basic Information, Manufacturing Base and Competitors
    Table 74. Hyamax Major Business
    Table 75. Hyamax Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 76. Hyamax Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Hyamax Recent Developments/Updates
    Table 78. Hyamax Competitive Strengths & Weaknesses
    Table 79. Allergan Aesthetics Basic Information, Manufacturing Base and Competitors
    Table 80. Allergan Aesthetics Major Business
    Table 81. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 82. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Allergan Aesthetics Recent Developments/Updates
    Table 84. Allergan Aesthetics Competitive Strengths & Weaknesses
    Table 85. CollPlant Basic Information, Manufacturing Base and Competitors
    Table 86. CollPlant Major Business
    Table 87. CollPlant Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 88. CollPlant Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. CollPlant Recent Developments/Updates
    Table 90. CollPlant Competitive Strengths & Weaknesses
    Table 91. Giant Biogene Holding Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 92. Giant Biogene Holding Co., Ltd Major Business
    Table 93. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 94. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Giant Biogene Holding Co., Ltd Recent Developments/Updates
    Table 96. Giant Biogene Holding Co., Ltd Competitive Strengths & Weaknesses
    Table 97. Jinbo Bio Basic Information, Manufacturing Base and Competitors
    Table 98. Jinbo Bio Major Business
    Table 99. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 100. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Jinbo Bio Recent Developments/Updates
    Table 102. Jinbo Bio Competitive Strengths & Weaknesses
    Table 103. Shuangmei Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 104. Shuangmei Biotechnology Co., Ltd Major Business
    Table 105. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 106. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Shuangmei Biotechnology Co., Ltd Recent Developments/Updates
    Table 108. Shuangmei Biotechnology Co., Ltd Competitive Strengths & Weaknesses
    Table 109. Bloomage Bio Basic Information, Manufacturing Base and Competitors
    Table 110. Bloomage Bio Major Business
    Table 111. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 112. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Bloomage Bio Recent Developments/Updates
    Table 114. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 115. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Major Business
    Table 116. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product and Services
    Table 117. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Recombinant Collagen Medical Aesthetic Injection Upstream (Raw Materials)
    Table 119. Recombinant Collagen Medical Aesthetic Injection Typical Customers
    Table 120. Recombinant Collagen Medical Aesthetic Injection Typical Distributors
List of Figure
    Figure 1. Recombinant Collagen Medical Aesthetic Injection Picture
    Figure 2. World Recombinant Collagen Medical Aesthetic Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Collagen Medical Aesthetic Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Collagen Medical Aesthetic Injection Production (2018-2029) & (K Units)
    Figure 5. World Recombinant Collagen Medical Aesthetic Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Collagen Medical Aesthetic Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Collagen Medical Aesthetic Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Recombinant Collagen Medical Aesthetic Injection Production (2018-2029) & (K Units)
    Figure 10. China Recombinant Collagen Medical Aesthetic Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Recombinant Collagen Medical Aesthetic Injection Production (2018-2029) & (K Units)
    Figure 12. Recombinant Collagen Medical Aesthetic Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Recombinant Collagen Medical Aesthetic Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Recombinant Collagen Medical Aesthetic Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Recombinant Collagen Medical Aesthetic Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Collagen Medical Aesthetic Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Collagen Medical Aesthetic Injection Markets in 2022
    Figure 26. United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Collagen Medical Aesthetic Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Collagen Medical Aesthetic Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Collagen Medical Aesthetic Injection Production Market Share 2022
    Figure 32. World Recombinant Collagen Medical Aesthetic Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Type in 2022
    Figure 34. Plant-derived Collagen
    Figure 35. Animal-derived Collagen
    Figure 36. World Recombinant Collagen Medical Aesthetic Injection Production Market Share by Type (2018-2029)
    Figure 37. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Type (2018-2029)
    Figure 38. World Recombinant Collagen Medical Aesthetic Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Recombinant Collagen Medical Aesthetic Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Application in 2022
    Figure 41. Hospital
    Figure 42. Beauty Agency
    Figure 43. World Recombinant Collagen Medical Aesthetic Injection Production Market Share by Application (2018-2029)
    Figure 44. World Recombinant Collagen Medical Aesthetic Injection Production Value Market Share by Application (2018-2029)
    Figure 45. World Recombinant Collagen Medical Aesthetic Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Recombinant Collagen Medical Aesthetic Injection Industry Chain
    Figure 47. Recombinant Collagen Medical Aesthetic Injection Procurement Model
    Figure 48. Recombinant Collagen Medical Aesthetic Injection Sales Model
    Figure 49. Recombinant Collagen Medical Aesthetic Injection Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Nasvita Medical
Mei Medica
Hyamax
Allergan Aesthetics
CollPlant
Giant Biogene Holding Co., Ltd
Jinbo Bio
Shuangmei Biotechnology Co., Ltd
Bloomage Bio
Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

Related Reports

Global Recombinant Collagen Medical Aesthetic Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Collagen Medical Aesthetic Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Sep 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Recombinant Collagen Medical Aesthetic Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Recombinant Collagen Medical Aesthetic Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Collagen Medical Aesthetic Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 19 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Recombinant Collagen Medical Aesthetic Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Recombinant Collagen Medical Aesthetic Injection

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>